A CBD nanoemulsion formulation normalized markers of inflammation, oxidative stress, and abnormal protein aggregation in both the brain and gut of rats with chemically induced Parkinson's-like disease.
Neuroscience researchers, Parkinson's disease investigators, and those interested in CBD's neuroprotective potential and novel drug delivery systems.
What the researchers found
CBD nanoemulsion treatment restored glutathione levels (which had dropped 38-47% from rotenone treatment), reduced alpha-synuclein accumulation in both the striatum and duodenum, and normalized glial activation markers GFAP and IBA1 to control levels.
Why it matters
Parkinson's disease often starts with gut symptoms before motor problems appear. This study is notable for examining CBD's effects in both the brain and the intestine simultaneously, reflecting the growing understanding that Parkinson's pathology involves the gut-brain axis.
The numbers in context
Rotenone caused 38-47% reduction in glutathione across brain regions (worst in striatum). CBD nanoemulsion at all three doses restored glutathione to control levels. Alpha-synuclein accumulation was reduced in both striatum and duodenum. Six experimental groups with behavioral and biochemical outcomes measured.
How the study worked
Wistar rats were divided into six groups receiving combinations of rotenone (Parkinson's model) and three doses of CBD nanoemulsion (1.25, 2.5, 5.0 mg/kg). Behavioral testing (open field, Y maze, novel object recognition) and biochemical, histological, and immunohistochemical analyses assessed outcomes in brain regions and duodenum.
What this study cannot tell us
Rat model of Parkinson's induced by chemical toxin does not fully replicate human disease. Nanoemulsion formulation may behave differently in humans. Short-term study does not assess whether protection persists. Multiple brain regions and outcome measures increase the chance of false positives.
How to read the evidence
Well-designed preclinical study with multiple doses and comprehensive outcome measures, but animal model results require human validation.
When this study was published
Published 2025.
The bigger picture
The gut-brain connection in Parkinson's is increasingly recognized, with alpha-synuclein pathology potentially spreading from the gut to the brain. CBD's ability to address pathology in both locations in this animal model aligns with the need for treatments that target this dual-site disease process.
Questions still open
- Whether the gut-protective effects of CBD could slow the progression of early-stage Parkinson's pathology in humans
- How the nanoemulsion formulation compares to standard CBD oil in delivering neuroprotective effects
Common questions
Why use a nanoemulsion instead of regular CBD oil?
Why did they look at the gut in a Parkinson's study?
Read the original research
Neuroprotective effects of a cannabidiol nanoemulsion in a rotenone-induced rat model of Parkinson's disease: Insights into the gut-brain axis.
European journal of pharmacology, 1002, 177748
Citation
Santos, Júlio César Claudino Dos; Aquino, Pedro Everson Alexandre de; Rebouças, Conceição da Silva Martins; Sallem, Camilla Costa; Guizardi, Marissa Prudente Pinheiro; Noleto, Felipe Micelli; Zampieri, Davila de Sousa; Ricardo, Nágila Maria Pontes Silva; Brito, Débora Hellen Almeida de; Silveira, Edilberto Rocha; Leitão, Renata Ferreira de Carvalho; Brito, Gerly Anne de Castro; Viana, Glauce Socorro de Barros. (2025). Neuroprotective effects of a cannabidiol nanoemulsion in a rotenone-induced rat model of Parkinson's disease: Insights into the gut-brain axis.. European journal of pharmacology, 1002, 177748. https://doi.org/10.1016/j.ejphar.2025.177748
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk
- Sublingual vs Oral vs Inhaled THC: How Absorption Changes the Experience